| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 156, Issue 4 1638-1645, Copyright © 1996 by American Association of Immunologists
ARTICLES |
RM Lafrenie, LM Wahl, JS Epstein, IK Hewlett, KM Yamada and S Dhawan
Laboratory of Developmental Biology, National Institute of Dental Research, Bethesda, MD 20892, USA.
Monocytes are major targets of HIV infection in patients with AIDS. In vitro infection of monocytes with HIV is associated with increased expression of beta 2 integrins, which increases both monocyte aggregation and monocyte/endothelial adhesion as well as monocyte metalloproteinase (MMP-9) expression. Treatment of primary monocytes with soluble HIV-Tat protein mimicked many of the properties of HIV infection of monocytes. Tat treatment up-regulated the expression of the beta 2 integrins, which was associated with the formation of large aggregates of monocytes and increased adhesion to endothelial monolayers. Treatment of monocytes with Tat increased their adhesion to both untreated and TNF-alpha-treated endothelial monolayers, and adhesion was inhibited by inclusion of anti-beta 2 and anti-ICAM-1 Abs. The increased adhesion of activated monocytes was accompanied by substantial disruption of the endothelial monolayers, with retraction or detachment of individual endothelial cells. Tat treatment of monocytes up-regulated the synthesis and release of the protease MMP-9, providing a potential mechanism to explain endothelial cell/basement membrane detachment. Thus, extracellular Tat is capable of activating monocytes even in the absence of HIV infection. Our studies demonstrate that many of the effects of HIV infection on monocyte homotypic and heterotypic adhesion, protease secretion, and disruption of the endothelium can be mimicked by treatment with HIV-Tat protein alone. These results suggest a mechanism where monocytes could be inappropriately activated by HIV-Tat, secreted by HIV-infected cells, causing them to extravasate into underlying tissues and ultimately contribute to tissue damage as seen during the progression of AIDS.
This article has been cited by other articles:
|
|
 |
|
  J. D. Easterbrook and S. L. Klein Corticosteroids modulate Seoul virus infection, regulatory T-cell responses and matrix metalloprotease 9 expression in male, but not female, Norway rats J. Gen. Virol., November 1, 2008; 89(11): 2723 - 2730. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Gupta, R. Boppana, G. C. Mishra, B. Saha, and D. Mitra HIV-1 Tat Suppresses gp120-Specific T Cell Response in IL-10-Dependent Manner J. Immunol., January 1, 2008; 180(1): 79 - 88. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Cheung, L. Pantanowitz, and B. J. Dezube AIDS-Related Malignancies: Emerging Challenges in the Era of Highly Active Antiretroviral Therapy Oncologist, June 1, 2005; 10(6): 412 - 426. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Devadas, N. J. Hardegen, L. M. Wahl, I. K. Hewlett, K. A. Clouse, K. M. Yamada, and S. Dhawan Mechanisms for Macrophage-Mediated HIV-1 Induction J. Immunol., December 1, 2004; 173(11): 6735 - 6744. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. S. Lee, P. Kalantari, S. Tsutsui{section}, A. Klatt, J. Holden, P. H. Correll, C. Power{section}, and A. J. Henderson RON Receptor Tyrosine Kinase, a Negative Regulator of Inflammation, Inhibits HIV-1 Transcription in Monocytes/Macrophages and Is Decreased in Brain Tissue from Patients with AIDS J. Immunol., December 1, 2004; 173(11): 6864 - 6872. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. O. Kim, Y. Liu, B. Y. Zhou, and J. J. He Induction of C Chemokine XCL1 (Lymphotactin/Single C Motif-1{alpha}/Activation-Induced, T Cell-Derived and Chemokine-Related Cytokine) Expression by HIV-1 Tat Protein J. Immunol., February 1, 2004; 172(3): 1888 - 1895. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.B. Sundstrom, D.E. Martinson, M. Mosunjac, P. Bostik, L.K. McMullan, R.M. Donahoe, M.B. Gravanis, and A.A. Ansari Norepinephrine Enhances Adhesion of HIV-1-Infected Leukocytes to Cardiac Microvascular Endothelial Cells Experimental Biology and Medicine, June 1, 2003; 228(6): 730 - 740. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T.-A. Kim, H. K. Avraham, Y.-H. Koh, S. Jiang, I.-W. Park, and S. Avraham HIV-1 Tat-Mediated Apoptosis in Human Brain Microvascular Endothelial Cells J. Immunol., March 1, 2003; 170(5): 2629 - 2637. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. M. Pieper, C. L. Olds, J. D. Bub, and P. F. Lindholm Transfection of human endothelial cells with HIV-1 tat gene activates NF-kappa B and enhances monocyte adhesion Am J Physiol Heart Circ Physiol, December 1, 2002; 283(6): H2315 - H2321. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Cota-Gomez, N. C. Flores, C. Cruz, A. Casullo, T. Y. Aw, H. Ichikawa, J. Schaack, R. Scheinman, and S. C. Flores The Human Immunodeficiency Virus-1 Tat Protein Activates Human Umbilical Vein Endothelial Cell E-selectin Expression via an NF-kappa B-dependent Mechanism J. Biol. Chem., April 19, 2002; 277(17): 14390 - 14399. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Barillari and B. Ensoli Angiogenic Effects of Extracellular Human Immunodeficiency Virus Type 1 Tat Protein and Its Role in the Pathogenesis of AIDS-Associated Kaposi's Sarcoma Clin. Microbiol. Rev., April 1, 2002; 15(2): 310 - 326. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Resino, J M Bellon, S Sanchez-Ramon, D Gurbindo, J Ruiz-Contreras, J A Leon, J T Ramos, and M A Munoz-Fernandez Impact of antiretroviral protocols on dynamics of AIDS progression markers Arch. Dis. Child., February 1, 2002; 86(2): 119 - 124. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Fanales-Belasio, S. Moretti, F. Nappi, G. Barillari, F. Micheletti, A. Cafaro, and B. Ensoli Native HIV-1 Tat Protein Targets Monocyte-Derived Dendritic Cells and Enhances Their Maturation, Function, and Antigen-Specific T Cell Responses J. Immunol., January 1, 2002; 168(1): 197 - 206. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Toschi, G. Barillari, C. Sgadari, I. Bacigalupo, A. Cereseto, D. Carlei, C. Palladino, C. Zietz, P. Leone, M. Sturzl, et al. Activation of Matrix-Metalloproteinase-2 and Membrane-Type-1-Matrix-Metalloproteinase in Endothelial Cells and Induction of Vascular Permeability In Vivo by Human Immunodeficiency Virus-1 Tat Protein and Basic Fibroblast Growth Factor Mol. Biol. Cell, October 1, 2001; 12(10): 2934 - 2946. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Misse, P.-O. Esteve, B. Renneboog, M. Vidal, M. Cerutti, Y. St Pierre, H. Yssel, M. Parmentier, and F. Veas HIV-1 glycoprotein 120 induces the MMP-9 cytopathogenic factor production that is abolished by inhibition of the p38 mitogen-activated protein kinase signaling pathway Blood, August 1, 2001; 98(3): 541 - 547. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Arese, C. Ferrandi, L. Primo, G. Camussi, and F. Bussolino HIV-1 Tat Protein Stimulates In Vivo Vascular Permeability and Lymphomononuclear Cell Recruitment J. Immunol., January 15, 2001; 166(2): 1380 - 1388. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I.-W. Park, J.-F. Wang, and J. E. Groopman HIV-1 Tat promotes monocyte chemoattractant protein-1 secretion followed by transmigration of monocytes Blood, January 15, 2001; 97(2): 352 - 358. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Prakash, Z.-Y. Tang, Y.-e He, M. S. Ali, R. Coleman, J. Gill, G. Farr, and F. Samaniego Human Kaposi's Sarcoma Cell-Mediated Tumorigenesis in Human Immunodeficiency Type 1 Tat-Expressing Transgenic Mice J Natl Cancer Inst, May 3, 2000; 92(9): 721 - 728. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Weiss, A. Nath, E. O. Major, and J. W. Berman HIV-1 Tat Induces Monocyte Chemoattractant Protein-1-Mediated Monocyte Transmigration Across a Model of the Human Blood-Brain Barrier and Up-Regulates CCR5 Expression on Human Monocytes J. Immunol., September 1, 1999; 163(5): 2953 - 2959. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Barillari, C. Sgadari, C. Palladino, R. Gendelman, A. Caputo, C. B. Morris, B. C. Nair, P. Markham, A. Nel, M. Sturzl, et al. Inflammatory Cytokines Synergize with the HIV-1 Tat Protein to Promote Angiogenesis and Kaposi's Sarcoma Via Induction of Basic Fibroblast Growth Factor and the {alpha}v{beta}3 Integrin J. Immunol., August 15, 1999; 163(4): 1929 - 1935. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Barillari, C. Sgadari, V. Fiorelli, F. Samaniego, S. Colombini, V. Manzari, A. Modesti, B. C. Nair, A. Cafaro, M. Sturzl, et al. The Tat Protein of Human Immunodeficiency Virus Type-1 Promotes Vascular Cell Growth and Locomotion by Engaging the alpha 5beta 1 and alpha vbeta 3 Integrins and by Mobilizing Sequestered Basic Fibroblast Growth Factor Blood, July 15, 1999; 94(2): 663 - 672. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Boykins, R. Mahieux, U. T. Shankavaram, Y. S. Gho, S. F. Lee, I. K. Hewlett, L. M. Wahl, H. K. Kleinman, J. N. Brady, K. M. Yamada, et al. Cutting Edge: A Short Polypeptide Domain of HIV-1-Tat Protein Mediates Pathogenesis J. Immunol., July 1, 1999; 163(1): 15 - 20. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Shutt and D. Soll HIV-induced T-cell syncytia release a two component T-helper cell chemoattractant composed of Nef and Tat J. Cell Sci., January 11, 1999; 112(22): 3931 - 3941. [Abstract] [PDF]
|
|
|
|
 |
|
 L. Huang, I. Bosch, W. Hofmann, J. Sodroski, and A. B. Pardee Tat Protein Induces Human Immunodeficiency Virus Type 1 (HIV-1) Coreceptors and Promotes Infection with both Macrophage-Tropic and T-Lymphotropic HIV-1 Strains J. Virol., November 1, 1998; 72(11): 8952 - 8960. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kumar, S. K. Manna, S. Dhawan, and B. B. Aggarwal HIV-Tat Protein Activates c-Jun N-Terminal Kinase and Activator Protein-1 J. Immunol., July 15, 1998; 161(2): 776 - 781. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Albini, R. Benelli, D. Giunciuglio, T. Cai, G. Mariani, S. Ferrini, and D. M. Noonan Identification of a Novel Domain of HIV Tat Involved in Monocyte Chemotaxis J. Biol. Chem., June 26, 1998; 273(26): 15895 - 15900. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. X. Wu and S. F. Schlossman Decreased ability of HIV-1 Tat protein-treated accessory cells to organize cellular clusters is associated with partial activation of T cells PNAS, December 9, 1997; 94(25): 13832 - 13837. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Mitola, S. Sozzani, W. Luini, L. Primo, A. Borsatti, H. Weich, and F. Bussolino Tat-Human Immunodeficiency Virus-1 Induces Human Monocyte Chemotaxis by Activation of Vascular Endothelial Growth Factor Receptor-1 Blood, August 15, 1997; 90(4): 1365 - 1372. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Dhawan, R. K. Puri, A. Kumar, H. Duplan, J.-M. Masson, and B. B. Aggarwal Human Immunodeficiency Virus-1-Tat Protein Induces the Cell Surface Expression of Endothelial Leukocyte Adhesion Molecule-1, Vascular Cell Adhesion Molecule-1, and Intercellular Adhesion Molecule-1 in Human Endothelial Cells Blood, August 15, 1997; 90(4): 1535 - 1544. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
